Search Within

Geoffrey Yuyat Ku

Formats
  1. Meeting Abstract (108)
  2. Journal Article (105)
  3. Book Section (11)
  4. Review (8)
  5. Guidelines (2)
  6. Conference Paper (1)
  7. Correspondence (1)
  8. Editorial (1)
  9. Miscellaneous (1)
  10. Research Letter (1)
Groups
  1. Department of Medicine (239)
  2. Gastrointestinal Oncology Service (239)
  3. Hematologic Malignancies, Division of (239)
  4. Solid Tumor Oncology Division (239)
  5. Center for Pancreatic Cancer Research (102)
  6. Epidemiology and Biostatistics (96)

More Groups

People
  1. David Ilson (123)
  2. Yelena Janjigian (110)
  3. Marinela Capanu (55)
  4. David Kelsen (53)
  5. Steven Maron (51)
  6. Laura Tang (49)

More People

Years
  1. 2025 (16)
  2. 2024 (19)
  3. 2023 (20)
  4. 2022 (19)
  5. 2021 (23)
  6. 2020 (18)

More Years

Publications
  1. Journal of Clinical Oncology (76)
  2. Annals of Oncology (22)
  3. Annals of Surgical Oncology (10)
  4. Clinical Cancer Research (10)
  5. International Journal of Radiation Oncology, Biology, Physics (7)
  6. Annals of Surgery (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (76)
  2. Oxford University Press (26)
  3. Elsevier Inc. (23)
  4. Springer (21)
  5. American Association for Cancer Research (14)
  6. Lippincott Williams & Wilkins (10)

More Publishers

Results (239)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genetic predictors of response to systemic therapy in esophagogastric cancer
    Journal Article

    Janjigian, Y. Y.; Sanchez-Vega, F.; Jonsson, P.; Chatila, W. K.; Hechtman, J. F.; Ku, G. Y.; Riches, J. C.; Tuvy, Y.; Kundra, R.; Bouvier, N.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Correlation of benefit from immune checkpoint inhibitors with next gen sequencing (NGS) profiles in esophagogastric cancer (EGC) patients
    Meeting Abstract

    Ku, G. Y.; Sanchez-Vega, F.; Chatila, W.; Margolis, M.; Fein, C.; Ilson, D. H.; Hechtman, J. F.; Tuvy, Y.; Bouvier, N.; Kundra, R.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Retrospective review of subsequent treatments (tx) for esophagogastric adenocarcinomas (EGA) refractory to FOLFOX
    Meeting Abstract

    Kelly, C. M.; Janjigian, Y. Y.; Kelsen, D. P.; Capanu, M.; Chou, J. F.; Ilson, D. H.; Ku, G. Y.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Utility of primary tumor resection in asymptomatic, unresectable metastatic colon and rectal cancer
    Journal Article

    Pezold, M.; Ku, G. K.; Temple, L. K.
    Difficult Decisions in Surgery: An Evidence-Based Approach (2017)

    Fulltext@MSK | Save
  • Systemic therapy for esophagogastric cancer: Targeted therapies
    Journal Article

    Lyons, T. G.; Ku, G. Y.
    Chinese Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Systemic therapy for esophageal cancer: Chemotherapy
    Journal Article

    Ku, G. Y.
    Chinese Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Systemic therapy for esophagogastric cancer: Immune checkpoint inhibition
    Journal Article

    Lyons, T. G.; Ku, G. Y.
    Chinese Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Preface on esophagus cancer
    Journal Article

    Ku, G. Y.; Ilson, D. H.
    Chinese Clinical Oncology (2017)

    Fulltext@MSK | Save
  • KEYNOTE-059 Update: Efficacy and safety of pembrolizumab alone or in combination with chemotherapy in patients with advanced gastric or gastroesophageal (G/GEJ) cancer
    Meeting Abstract

    Wainberg, Z. A.; Jalal, S.; Muro, K.; Yoon, H. H.; Garrido, M.; Golan, T.; Doi, T.; Catenacci, D. V.; Geva, R.; Ku, G.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Targeted first-line therapies for advanced colorectal cancer: A Bayesian meta-analysis
    Journal Article

    Ridouane, Y.; Lopes, G.; Ku, G.; Masud, H.; Haaland, B.
    Oncotarget (2017)

    Fulltext@MSK | Save